Exclusive Cooperation between ARTES and the Ukrainian National Academy of Sciences
The technology licensed to ARTES covers new expression tools as well as production cell lines for various products, a.o. HepB antigen and Arginase. With this agreement ARTES expands its Hansenula technology platform and gains access to new processes and products.
"With the input from NAS", said Michael Piontek the managing director from ARTES, "we are now once again able to broaden up our expertise in the Hansenula research field. This newest collaboration enables us even more to expand our previous offer and especially with the view of East-European markets we had won an important academic research partner."
ARTES Biotechnology GmbH
ARTES is a Germany-based biotechnology company specialized in recombinant protein production from yeast expression systems. ARTES offers generation of optimized production cell lines in proprietary yeast expression systems based on Hansenula polymorpha and Arxula adeninivorans. In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization. ARTES operates worldwide from its 850 sqm S1 facilities in Langenfeld near Duesseldorf. The company is a strategic partner for the chemical and pharmaceutical industry, developing cost-efficient production processes for internationally marketed products on a contract R&D basis.